Thomas Reiser/LinkedIn
Oct 18, 2025, 05:21
Thomas Reiser: ISTH Guidelines and Guidance Committee Invites Public Comments on the Guidance Manuscript
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
“Your expertise is requested!
The International Society on Thrombosis and Haemostasis (ISTH) Guidelines & Guidance Committee invites public comments on the guidance manuscript, “Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the SSC Subcommittee on Pediatrics & Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group”
Deadline: Oct. 30″
Register here.
Stay informed with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp